Mortality from Nonmelanoma Skin Cancer in Australia from 1971 to 2021

被引:2
作者
Czarnecki, D. [1 ]
机构
[1] Doctors Care Clin, 157 Scoresby Rd, Boronia, Vic 3155, Australia
关键词
nonmelanoma skin cancer; mortality; population change; SQUAMOUS-CELL CARCINOMA; INCIDENCE RATES; METASTASES; MELANOMA; BURDEN;
D O I
10.3390/cancers16050867
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The study examined the number of deaths from nonmelanoma skin cancer (NMSC) in Australia for the fifty years from 1971 to 2021. Australia has the highest reported incidences of NMSC in the world. Deaths from NMSC have been recorded since 1971 and have increased more than five-fold in the 50 years to 2021. There is no sign of a reduction in the increasing incidence of deaths from NMSC. Most deaths from NMSC are due to cutaneous squamous cell carcinoma (SCC). It is estimated that 1 in 260 cutaneous SCCs will metastasize and cause death.Abstract The number of non-melanoma skin cancers (NMSC) removed from Australians is increasing every year. The number of deaths from NMSC is increasing but so is the population. However, the population has greatly changed with many dark-skinned people migrating to Australia. These people are at low risk for skin cancer even if they live all their lives in Australia. The susceptible population is the rest of the population. The death rate from NMSC for the entire population and susceptible populations since 1971 is examined in this article. Materials and methods: Data on the Australian population were obtained from the Australian Bureau of Statistics (ABS). Every five years a census is held in Australia and detailed information of the population is provided. The ABS also provided yearly data on the causes of death in Australia. Results: The total population increased from 12,755,638 in 1971 to 25,738,140 in 2021. However, the susceptible population increased by far less, from 12,493,780 to 19,773,783. The number of deaths from NMSC increased from 143 to 765. The crude death rate for the susceptible population increased from 1.1 per 100,000 to 3.9 per 100,000. The crude death rate in the susceptible population aged 65 or more increased from 9.4 to 18.2 per 100,000. Conclusion: Deaths from NMSC are increasing despite public health campaigns to prevent skin cancer. According to current trends, NMSC will cause more deaths than melanoma in Australia.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] microRNA profiling for early detection of nonmelanoma skin cancer
    Balci, S.
    Ayaz, L.
    Gorur, A.
    Yaroglu, H. Yildirim
    Akbayir, S.
    Unal, N. Dogruer
    Bulut, B.
    Tursen, U.
    Tamer, L.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2016, 41 (04) : 346 - 351
  • [32] Immunotherapy for nonmelanoma skin cancer - Does it have a future?
    Urosevic, M
    Dummer, R
    CANCER, 2002, 94 (02) : 477 - 485
  • [33] A review of heart transplant immunosuppressants and nonmelanoma skin cancer
    Eckembrecher, Daphne G.
    Eckembrecher, Francelia J.
    Camacho, Isabella
    Shah, Hemali
    Dave, Yogi
    Patel, Shrey
    Nouri, Keyvan
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2023, 315 (09) : 2491 - 2503
  • [34] An update on local and systemic therapies for nonmelanoma skin cancer
    Elleson, Kelly M.
    DePalo, Danielle K.
    Zager, Jonathan S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (05) : 479 - 489
  • [35] Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients
    Rodrigues, Michelle
    DERMATOLOGIC CLINICS, 2017, 35 (02) : 129 - +
  • [36] Nonmelanoma Skin Cancer in Nonwhite Organ Transplant Recipients
    Pritchett, Ellen N.
    Doyle, Alden
    Shaver, Christine M.
    Miller, Brett
    Abdelmalek, Mark
    Cusack, Carrie Ann
    Malat, Gregory E.
    Chung, Christina Lee
    JAMA DERMATOLOGY, 2016, 152 (12) : 1348 - 1353
  • [37] Therapeutic Cancer Vaccines for Nonmelanoma Skin Cancer
    Shou-En Wu
    Yi-Hsien Chen
    Chih-Tsung Hung
    Bing-Heng Yang
    Current Treatment Options in Oncology, 2023, 24 : 496 - 514
  • [38] Genetics and nonmelanoma skin cancer in kidney transplant recipients
    Burke, Michael T.
    Isbel, Nicole
    Barraclough, Katherine A.
    Jung, Ji-Won
    Wells, James W.
    Staatz, Christine E.
    PHARMACOGENOMICS, 2015, 16 (02) : 161 - 172
  • [39] Surgical Outcomes for Nonmelanoma Skin Cancer of the Head and Neck
    Liu, Hua
    Dai, Xiaoming
    ANNALS OF PLASTIC SURGERY, 2025, 94 (04) : 443 - 446
  • [40] Current Research in Melanoma and Aggressive Nonmelanoma Skin Cancer
    Wilken, Reason
    Criscito, Maressa
    Pavlick, Anna C.
    Stevenson, Mary L.
    Carucci, John A.
    FACIAL PLASTIC SURGERY, 2020, 36 (02) : 200 - 210